Statin Intolerance: the Clinician's Perspective

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F15%3A10313180" target="_blank" >RIV/00216208:11110/15:10313180 - isvavai.cz</a>

Nalezeny alternativní kódy

RIV/00064165:_____/15:10313180

Výsledek na webu

<a href="http://dx.doi.org/10.1007/s11883-015-0552-3" target="_blank" >http://dx.doi.org/10.1007/s11883-015-0552-3</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1007/s11883-015-0552-3" target="_blank" >10.1007/s11883-015-0552-3</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Statin Intolerance: the Clinician's Perspective

Popis výsledku v původním jazyce

Muscle problems and other adverse symptoms associated with statin use are frequent reasons for non-adherence and discontinuation of statin therapy, which results in inadequate control of hyperlipidemia and increased cardiovascular risk. However, most patients who experience adverse symptoms during statin use are able to tolerate at least some degree of statin therapy. Given the profound cardiovascular benefits derived from statins, an adequate practical approach to statin intolerance is, therefore, of great clinical importance. Statin intolerance can be defined as the occurrence of myalgia or other adverse symptoms that are attributed to statin therapy and that lead to its discontinuation. In reality, these symptoms are actually unrelated to statin usein many patients, especially in those with atypical presentations following long periods of treatment. Thus, the first step in approaching patients with adverse symptoms during the course of statin therapy is identification of those pati

Název v anglickém jazyce

Statin Intolerance: the Clinician's Perspective

Popis výsledku anglicky

Muscle problems and other adverse symptoms associated with statin use are frequent reasons for non-adherence and discontinuation of statin therapy, which results in inadequate control of hyperlipidemia and increased cardiovascular risk. However, most patients who experience adverse symptoms during statin use are able to tolerate at least some degree of statin therapy. Given the profound cardiovascular benefits derived from statins, an adequate practical approach to statin intolerance is, therefore, of great clinical importance. Statin intolerance can be defined as the occurrence of myalgia or other adverse symptoms that are attributed to statin therapy and that lead to its discontinuation. In reality, these symptoms are actually unrelated to statin usein many patients, especially in those with atypical presentations following long periods of treatment. Thus, the first step in approaching patients with adverse symptoms during the course of statin therapy is identification of those pati

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FA - Kardiovaskulární nemoci včetně kardiochirurgie

OECD FORD obor

—

Projekt

<a href="/cs/project/NT12217" target="_blank" >NT12217: Genetické faktory určující riziko aterotrombotických cévních příhod u nemocných bez klasických rizikových faktorů aterosklerózy a u pacientů léčených statinem</a><br>

Návaznosti

V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Rok uplatnění

2015

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Current Atherosclerosis Reports

ISSN

1523-3804

e-ISSN

—

Svazek periodika

17

Číslo periodika v rámci svazku

12

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

7

Strana od-do

—

Kód UT WoS článku

000364521700004

EID výsledku v databázi Scopus

2-s2.0-84944725737